Anika Therapeutics Inc
F:AKP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Anika Therapeutics Inc
F:AKP
|
US |
|
M
|
Mitsubishi Chemical Group Corp
DUS:M3C
|
JP |
|
N
|
North East Rubber PCL
SET:NER
|
TH |
|
Nexpoint Real Estate Finance Inc
NYSE:NREF
|
US |
|
S
|
Stanley Black & Decker Inc
DUS:SWF
|
US |
|
Acconeer AB
F:2LU
|
SE |
|
Vale SA
NYSE:VALE
|
BR |
|
Spire Global Inc
F:EL9
|
US |
|
Prosegur Compania de Seguridad SA
OTC:PGCSF
|
ES |
|
Electronic Arts Inc
NASDAQ:EA
|
US |
|
Datatec Ltd
OTC:DTTLY
|
ZA |
|
D
|
Devon Energy Corp
F:DY6
|
US |
Wall St Price Targets
AKP Price Targets Summary
Anika Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AKP is 9.87 EUR with a low forecast of 9.49 EUR and a high forecast of 10.45 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AKP's stock price target?
Price Target
9.87
EUR
According to Wall Street analysts, the average 1-year price target for AKP is 9.87 EUR with a low forecast of 9.49 EUR and a high forecast of 10.45 EUR.
What is the Revenue forecast for Anika Therapeutics Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Anika Therapeutics Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 2 years is 6%.
